🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest

Search Results

Found 147 results for "uk" across articles, medicines, trials, companies and the glossary

TMC Pharma Services Acquires tranScrip to Expand Global Life Science Regulatory and Medical Consulting Capabilities
Industry
TMC Pharma Services Acquires tranScrip to Expand Global Life Science Regulatory and Medical Consulting Capabilities
TMC Pharma Services has acquired contract drug development organization tranScrip, combining clinical trial execution and contract research with deep regulatory affairs, medical, and scientific advisory services.
3 hrs ago
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Industry
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
A comprehensive guide to utilizing Priya Life Science's live trackers. Learn how to track clinical trials, regulatory recalls, drug shortages, biotech layoffs, and M&A venture activity to accelerate your career and optimize market intelligence.
5 days ago
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Industry
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
08 Aug 2026
The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery
Industry
The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery
As direct-to-patient dispensing platforms like LillyDirect expand across the UK and digital healthcare alters prescription delivery, community pharmacists in Ireland and Great Britain are adapting. This critical analysis examines the impact of mail-order platforms, recent regulatory shifts in Ireland, and how local chemists are pivoting to clinical primary care services.
08 Aug 2026
GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons
Industry
GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons
An in-depth clinical and market analysis of GLP-1 therapeutics in 2026, examining central brain reward circuit mapping from the University of Virginia, Phase 3 oral small-molecule data for Orforglipron, Retatrutide triple-agonist efficacy, and systemic cardiometabolic benefits.
08 Aug 2026
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Industry
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Global equity markets open August 2026 on a historic high as rumored $400B AstraZeneca-BMS merger talks and Curium's $8B Lantheus acquisition spark a massive biopharmaceutical consolidation wave.
03 Aug 2026
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
29 Jul 2026
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
29 Jul 2026
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
Industry
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.
29 Jul 2026
UK Pharma CV Guide 2026: MHRA Standards, Golden Triangle Hubs & Free ATS CV Builder
Industry
UK Pharma CV Guide 2026: MHRA Standards, Golden Triangle Hubs & Free ATS CV Builder
Complete 2026 guide to writing an ATS-compliant pharmaceutical CV in the UK. Features MHRA & ABPI standards, UK 2-page CV conventions, Golden Triangle recruitment benchmarks, and free ATS CV Studio tools.
22 Jul 2026
Global Pharma Talent Corridor: Writing a Cross-Border CV for India, Ireland, UK & US Roles
Industry
Global Pharma Talent Corridor: Writing a Cross-Border CV for India, Ireland, UK & US Roles
The ultimate 2026 guide for international life science professionals moving between India, Ireland, the UK, and the US. Learn how to format GxP experience, CDMO backgrounds, and visa-ready ATS CVs.
22 Jul 2026
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
Industry
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.
22 Jul 2026
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
Industry
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
GEODIS opens a state-of-the-art GDP-compliant pharmaceutical hub in Sharston Green, South Manchester, offering 2,000 pallet positions, 15-25°C and 2-8°C climate-controlled storage, and direct air/sea connectivity to Ireland and global markets.
22 Jul 2026
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
20 Jul 2026
Enterprise Ireland Funding Programmes 2026: The Complete Founder’s Guide to Grants, Pre-Seed (PSSF), iHPSU & Founder Visas
Industry
Enterprise Ireland Funding Programmes 2026: The Complete Founder’s Guide to Grants, Pre-Seed (PSSF), iHPSU & Founder Visas
Master Enterprise Ireland's funding ecosystem: from Pre-Seed Start Fund (€50k-€100k) and Innovative HPSU Fund (€1.2M) to R&D, Green, and Digitalisation vouchers. Includes step-by-step application advice, readiness timelines, and non-EU founder visa rules.
20 Jul 2026
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
18 Jul 2026
The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories
Regulatory Affairs
The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories
An in-depth commercial analysis of the UK-India Comprehensive Economic and Trade Agreement (CETA), exploring its transformative impact on bilateral pharmaceutical manufacturing, active pharmaceutical ingredient (API) supply chains, and consumer medicine pricing.
18 Jul 2026
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
18 Jul 2026
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
16 Jul 2026
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Biotechnology
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.
15 Jul 2026
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
08 Jul 2026
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
08 Jul 2026
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
Regulatory Affairs
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
The UK government and the pharmaceutical industry have launched a series of pilot schemes designed to accelerate NHS patient access to innovative medicines - a direct consequence of the US-UK pharmaceutical trade arrangement that has already rewritten the terms of how Britain prices, approves, and funds new drugs. But with a BMJ analysis warning of £45 billion in diverted NHS resources and up to 229,000 excess deaths by 2036, the pilots are arriving in the middle of one of the most contested healthcare policy disputes in a generation.
06 Jul 2026
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
Industry
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
Co-founded by Patrick Murphy and David Kelly, Tapestry VC has announced the closing of its $80 million Fund III, tripling its capital base with support from OpenAI CFO Sarah Friar and the British Business Bank.
05 Jul 2026
AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows
MedTech
AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows
Build, a startup co-founded by James Stirrat-Ellis and Ben McClusky, has secured $8.5 million in seed funding led by Index Ventures to expand Dougie, its AI platform for real estate infrastructure workflows.
05 Jul 2026
GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks
Industry
GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks
Co-founded by Habs Isabelle Kim and Dermot O'Riordan, government technology startup Xylo has raised £2.8 million in pre-seed funding to deploy AI agents that speed up local planning departments.
05 Jul 2026
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
Industry
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
An in-depth analysis of two newly opened funding opportunities-Women TechEU and Innovate UK's Next Wave Createch-designed to support early-stage deep tech and creative technology innovators across Europe and the UK.
02 Jul 2026
HR Duo Raises €1.6 Million from Puma Growth Partners and Enterprise Ireland to Accelerate UK Expansion
Industry
HR Duo Raises €1.6 Million from Puma Growth Partners and Enterprise Ireland to Accelerate UK Expansion
Workforce management SaaS platform HR Duo has closed a €1.6 million funding round backed by Puma Growth Partners and Enterprise Ireland to scale its automated HR and compliance services for SMEs in frontline industries.
29 Jun 2026
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
Industry
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
Launched in Dundalk, the three-year Public Health Knowledge Hub (PHKH) project brings together the Institute of Public Health, Trinity College Dublin, and Ulster University to build the first-ever harmonised cross-border public health data portal.
28 Jun 2026
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
27 Jun 2026
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
Regulatory Affairs
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.
27 Jun 2026
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
Regulatory Affairs
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.
25 Jun 2026
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
25 Jun 2026
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Regulatory Affairs
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Eli Lilly has successfully brought its LillyDirect service to the UK. Adapted to comply with strict local regulations, the service partners with regulated healthcare organizations to offer secure, anti-counterfeit delivery of high-demand therapies like Mounjaro directly to patients' doors.
25 Jun 2026
Galen’s Penthrox Inhaler Secures Expanded UK License for Paediatric Trauma Pain
Industry
Galen’s Penthrox Inhaler Secures Expanded UK License for Paediatric Trauma Pain
Northern Ireland-based Galen has received an expanded UK license for its emergency pain relief inhaler, Penthrox (methoxyflurane). The self-administered "green whistle" is now officially approved for use in conscious children aged six and older suffering from trauma-associated pain.
25 Jun 2026
From Farming to Pharma: The History of Ireland’s Life Sciences Revolution
Biotechnology
From Farming to Pharma: The History of Ireland’s Life Sciences Revolution
How did a nation once defined by agriculture and emigration transform into the world’s third-largest exporter of pharmaceuticals? We trace the deliberate policy shifts, educational reforms, and FDI strategies that built Ireland’s booming life sciences ecosystem.
25 Jun 2026
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Regulatory Affairs
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
25 Jun 2026
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Industry
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
25 Jun 2026
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
LinkedIn
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.
22 Jun 2026
How to Highlight Regulatory Affairs and Compliance Expertise on Your LinkedIn Profile
LinkedIn
How to Highlight Regulatory Affairs and Compliance Expertise on Your LinkedIn Profile
A detailed step-by-step LinkedIn guide for Regulatory Affairs Specialists, Quality Assurance professionals, Pharmacovigilance Officers, CMC Scientists, and all pharmaceutical compliance professionals. Learn exactly how to frame your regulatory expertise on LinkedIn to attract the right roles, visibility, and recognition - without exposing proprietary submissions or confidential regulatory strategy.
22 Jun 2026
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
22 Jun 2026
Eisai Allocates £48M to UK Cold-Chain Pharma Packaging Hub
Pharmaceutical
Eisai Allocates £48M to UK Cold-Chain Pharma Packaging Hub
Japanese pharmaceutical company Eisai announces a £48 million investment at its Hatfield, UK site to establish advanced cold-chain supply and packaging capabilities, supported by the Life Sciences Innovative Manufacturing Fund.
22 Jun 2026
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Ireland’s Pharmaceutical Value Chains in 2026
Industry
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Ireland’s Pharmaceutical Value Chains in 2026
With the US-Iran peace deal signed and the Strait of Hormuz set to reopen, Ireland's pharmaceutical export sector stands to benefit from stabilized global energy tariffs, normalized maritime trade corridors, and renewed multinational capital inflows.
21 Jun 2026
Ireland Announces Major Updates to Employment Permit Occupation Lists
Industry
Ireland Announces Major Updates to Employment Permit Occupation Lists
A detailed analytical deep-dive into the Irish Government's 2026 updates to Critical Skills and General Employment Permit lists, reviewing quotas, key sectors, and the proposed changes to the 50:50 rule.
21 Jun 2026
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
Industry
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
AbbVie is reportedly in advanced negotiations to acquire clinical-stage biotech Apogee Therapeutics for approximately $10.9 billion in cash, aiming to secure the promising long-acting eczema therapy zumilokibart.
19 Jun 2026
Laprophan Accelerates International Expansion with Completion of Rivopharm Acquisition in Switzerland
Industry
Laprophan Accelerates International Expansion with Completion of Rivopharm Acquisition in Switzerland
Moroccan pharmaceutical group Laprophan finalizes its acquisition of a controlling stake in Swiss pharmaceutical firm Rivopharm, securing a strategic industrial base in Europe and expanding its global footprint.
18 Jun 2026
Jazz Pharmaceuticals Strikes Strategic $820M Research Deal with AbCellera for Next-Gen T-Cell Engaging Antibodies
Industry
Jazz Pharmaceuticals Strikes Strategic $820M Research Deal with AbCellera for Next-Gen T-Cell Engaging Antibodies
Discover how Jazz Pharmaceuticals and AbCellera are joining forces in a high-stakes, $820M biopharma collaboration to pioneer next-generation T-cell engaging (TCE) multispecific antibodies targeting gastrointestinal cancers and challenging solid tumors.
18 Jun 2026
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
Pharmaceutical
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.
16 Jun 2026
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Pharmaceutical
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Enterprise Ireland has announced record total exports of €38.86 billion. With the Advanced Manufacturing and Life Sciences sector surging by 14% to €13.16 billion, we analyse what this means for Ireland's homegrown pharma ecosystem.
16 Jun 2026
Emerging Pharma Companies in Ireland to Watch in 2026
MedTech
Emerging Pharma Companies in Ireland to Watch in 2026
Discover the top 5 high-growth Irish life science, biotech, and medtech companies transforming the healthcare landscape. From Enterprise Ireland backed startups to global scale-ups, these are the emerging leaders of 2026.
12 Jun 2026